Drug Hepatotoxicity, An Issue of Clinics in Liver Disease: Volume 24-1

CHF 121.15
Auf Lager
SKU
HEPFNHP8371
Stock 1 Verfügbar
Geliefert zwischen Fr., 07.11.2025 und Mo., 10.11.2025

Details

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI). Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09780323708579
    • Editor Pierre Gholam
    • Sprache Englisch
    • Genre Medical Books
    • Größe H229mm x B152mm x T14mm
    • Jahr 2019
    • EAN 9780323708579
    • Format Fester Einband
    • ISBN 978-0-323-70857-9
    • Veröffentlichung 21.11.2019
    • Titel Drug Hepatotoxicity, An Issue of Clinics in Liver Disease: Volume 24-1
    • Gewicht 390g
    • Herausgeber Elsevier Health Science

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470